Musculoskeletal startup Hinge Health acquired Enso
The Enso’s device is used in the treatment of chronic and acute pain at over 100 medical centers in the U.S. such as Harvard, Stanford and Cedars-Sinai
In March 9, 2021 Hinge acquires Enso to expand its pain management technology. Medical devices company Enso had developed a noninvasive device shown which reduce the pain by 56 percent as per the results of double-blind clinical trials. Enso’s device delivers an electrical stimulation treatment that relaxes the muscles and helps in musculoskeletal therapy. This device also calms the nerves and it is controlled by the smartphones via app.
The Enso’s device is used in the treatment of chronic and acute pain at over 100 medical centers in the U.S. such as Harvard, Stanford and Cedars-Sinai. Terms and conditions of the deal were not disclosed by the company. On the other hand, Hinge Health offers a digital platform that utilizes wearable sensors. Hinge also provides one to one health coaching to deliver the in-home musculoskeletal therapy.
“Combining Hinge Health’s digital MSK clinic with Enso’s non-invasive high-frequency impulse technology opens a new world of pain management. Now Hinge Health’s members can access the same clinically effective solution we’ve recommended to thousands of our own patients,” said Amitabh Gulati, M.D., director of the Chronic Pain Fellowship at the Cornell Weill School of Medicine and president of the World Academy of Pain Medicine.
